Gene expression studies using a miniaturized thermal cycler system on board the International Space Station

The distance and duration of human spaceflight missions is set to markedly increase over the coming decade as we prepare to send astronauts to Mars. However, the health impact of long-term exposure to cosmic radiation and microgravity is not fully understood. In order to identify the molecular mecha...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 13; no. 10; p. e0205852
Main Authors Montague, Tessa G, Almansoori, Alia, Gleason, Emily J, Copeland, D Scott, Foley, Kevin, Kraves, Sebastian, Alvarez Saavedra, Ezequiel
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 31.10.2018
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The distance and duration of human spaceflight missions is set to markedly increase over the coming decade as we prepare to send astronauts to Mars. However, the health impact of long-term exposure to cosmic radiation and microgravity is not fully understood. In order to identify the molecular mechanisms underpinning the effects of space travel on human health, we must develop the capacity to monitor changes in gene expression and DNA integrity in space. Here, we report successful implementation of three molecular biology procedures on board the International Space Station (ISS) using a miniaturized thermal cycler system and C. elegans as a model organism: first, DNA extraction-the initial step for any type of DNA analysis; second, reverse transcription of RNA to generate complementary DNA (cDNA); and third, the subsequent semi-quantitative PCR amplification of cDNA to analyze gene expression changes in space. These molecular procedures represent a significant expansion of the budding molecular biology capabilities of the ISS and will permit more complex analyses of space-induced genetic changes during spaceflight missions aboard the ISS and beyond.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: E.A.S. and S.K. are employed by miniPCR, manufacturer of the device used for DNA amplification. The remaining authors declare no competing financial interests.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0205852